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and RAPD4, with environmental resource. The major RAPD proﬁle
was RAPD1 proﬁle (n=64, 50.4%), which includes 31 (72.1%) MDR
isolates with one environmental reservoir. In summery we found
three different proﬁles for MDR strains. Different RAPD proﬁles
suggested the different exogenous or endogenous sources of
infection.
Conclusion: Our ﬁndings highlighted the need for further at-
tention to disinfection inanimate hospital environment to limit
transfer of P. aeruginosa in this BU; moreover, use of some
antimicrobial agents must be restricted.
PP-017 The primary investigation of catheter-related
infection in severe patients of emergency
intensive care unit of Ruijin Hospital
Zai-Qian Che*, Yi-Jun Yang, Zhi-Tao Yang, Feng Jing,
Er-Zhen Chen. Emergency Intensive Care Unit, Ruijin Hospital,
Shanghai, China
Background: Infection control is of key importance especially in
critically ill patients. We investigated catheter-related infections
retrospectively in severe patients in Emergency intensive care
unit (EICU) in our hospital in order to adopt effective measures
to decrease mortality in severe patients.
Methods: The patient’s data (from May, 2008 to January,
2009) were collected retrospectively, including ICU stay, day of
catheterization (central line, urinary catheter, artiﬁcial airway),
number of catheter infection and catheter-related bloodstream
infection, number of catheter-related urinary system infection,
number of hospital-acquired pneumonia (HAP) and ventilator-
associated pneumonia (VAP), and microbiological culture results
of sputum at different stages, respectively. Catheter -associated
infection rate (per 1000 device-days) was calculated according to
the National Nosocomial Infections Surveillance (NNIS) System.
Results: A total number of 153 severe patients were enrolled in
the study and the total hospitalization day was 3023. Catheter
-associated infection rate (per 1000 device-days) was 6.89 for
central catheter, 8.91 for urinary catheter and 33.11 for artiﬁcial
airway. The incidence rate of HAP is 21.57%, of which 44.12%
was VAP. 84.62% of patients received mechanical ventilation
more than 7 days presents VAP. The main pathogens of HAP
were gram negative bacteria, 81.64% (80/98), followed by gram
positive bacteria, 81.64% (18/98), which was mainly composed
of MRSA(+) bacteria (77.78%). Non-fermentation gram negative
bacilli (NFGNB) were the major component of gram negative
bacteria (67.5%).
Conclusion: Our rates of catheter-associated infection (per 1000
device-days) are higher than the corresponding NNIS rates in
2008.
PP-018 Botryomycosis as a umbilical nodule, as a
diferential diagnosis for umbilical hernia
Guilherme Peterson*, Tomaz Grezzana. Hospital de Clinicas de
Porto Alegre
Case Description: A 54 year old obese woman presented with
chronic periumbilical pain. An ultrasound showed a nodule in
the umbilicus, presumably an umbilical hernia. During surgery an
abscess in the aponeurosis, under the umbilicum was identiﬁed.
Transoperatory frozen section examination showed no cellular
displasia. Deﬁnitive anatomopathological examination showed
bacterial and ﬁbrous tissue, consistent with botryomycosis. Gram
positive cocci strains and gram negative baccilus were isolated
from the secretion, no bacteria growth was identiﬁed in cultures.
Revision of literature: Botryomycosis is a rare bacterial chronic
infection, mostly seen in skin and cutaneous tissue, but also
described in lung, liver, spleen and other viscera. It is more
frequently associated to imunossupressed individuals, such as
AIDS, alcoholism and diabetes mellitus.
Few cases of botryomycosis of the abdominal wall were de-
scribed, and mostly were related to uterine devices, in such case
Actinomyces were isolated.
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Objectives: to evaluate the in vitro activity of tigecycline against
panresistant K. pneumoniae clinical isolates from ICU patients
with nosocomial infection.
Methods: We examined 13 non duplicated panresistant K. pneu-
moniae isolates recovered 10 from blood cultures, 1 from urine
sample, 1 from nose and 1from bed derived from ICU-patients
during June 2008 to February 2009. The identiﬁcation of the iso-
lates and the susceptibility testing were performed by the VITEK
2 system (bioMerieux®, France). The susceptibility testing for
tigecycline was performed by Kirby-Bauer disk diffusion method.
Paper disks containing tigecycline at 15 μg per disk were used
(Oxoid Ltd, England). The determination of tigecycline MICs val-
ues was performed by E-test strips (AB-Biodisk, Sweden). Isolates
with an inhibition zone diameter of ≥19 mm and with an MIC
level ≤1 μg/mL were considered as susceptible to tigecycline
(MIC susceptibility limits determined by EUCAST). All isolates
were screened for MBL production and for extended-spectrum
β-lactamase. K. pneumoniae ATCC 70603 was used as a positive
ESBLs strain.
Results: All the K. pneumoniae clinical isolates were resistant to
b-lactams, aminoglycosides, carbapenems, monobactames, ce-
falosporines, furanes, cinolones and colistin.The phenotypic test
for ESBL-production was positive in all isolates that were identi-
ﬁed as possible KPC-producers. The tigecycline was found abso-
lute active to all the examined isolates. The inhibition diameter
zones were found of ≥21 mm and the MIC levels of <0.5 μg/mL.
Conclusion: Tigecycline is absolute active to panresistant
K. pneumoniae isolates. Tigecycline presented consistently low
MIC90 values and broad spectrum of activity, including otherwise
resistant strains.
PP-020 A comparative study of therapeutic effects of
Zataria Multiﬂora vaginal cream and
metronidazole vaginal gel on bacterial vaginosis
Masoumeh Simbar*,1, Zohreh Azarbad2. 1Shahid Beheshti
Medical Science University; 2Kashan Medical Science University
Introduction: Bacterial vaginosis (BV) is one of most prevalent
complications among reproductive aged women. Metromidazole
prescription which is considered as the ﬁrst line treatment of BV
